newsfilter
← Earnings
Earnings Releases·

BillionToOne — Third Quarter 2026 Earnings Summary

BillionToOne reported third-quarter 2026 total revenue of $123.0 million, representing a 47% increase from the prior year period. The company delivered 206,000 tests during the quarter, with prenatal clinical testing revenue rising 41% to $104.3 million and oncology revenue surging 96% to $17.1 million. BillionToOne raised its full-year 2026 revenue guidance to a range of $460 million to $470 million and announced the upcoming December 15, 2026 launch of its Northstar Clear tissue-free MRD test.

Company
BILLIONTOONE INC
Sector
Healthcare
Industry
Diagnostics & Research